Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Correction to: Multidisciplinary treatment for locally advanced breast cancer with internal mammary lymph node metastasis in an elderly patient.

Takuwa H, Tsuji W, Yamamoto Y, Yamauchi C, Yotsumoto F.

Int Cancer Conf J. 2019 Sep 3;8(4):195-196. doi: 10.1007/s13691-019-00386-2. eCollection 2019 Oct.

2.

Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study.

Cellier C, Bouma G, van Gils T, Khater S, Malamut G, Crespo L, Collin P, Green PHR, Crowe SE, Tsuji W, Butz E, Cerf-Bensussan N, Macintyre E, Parnes JR, Leon F, Hermine O, Mulder CJ; RCD-II Study Group Investigators.

Lancet Gastroenterol Hepatol. 2019 Dec;4(12):960-970. doi: 10.1016/S2468-1253(19)30265-1. Epub 2019 Sep 4.

PMID:
31494097
3.

Pegfilgrastim-induced fatigue and leukocytosis improved following dose reduction in a young patient with breast cancer: A case report.

Takuwa H, Tsuji W, Goto T, Otsuji T, Yotsumoto F.

Mol Clin Oncol. 2019 Oct;11(4):371-375. doi: 10.3892/mco.2019.1907. Epub 2019 Aug 7.

4.

Multidisciplinary treatment for locally advanced breast cancer with internal mammary lymph node metastasis in an elderly patient.

Takuwa H, Tsuji W, Yamamoto Y, Yamauchi C, Yotsumoto F.

Int Cancer Conf J. 2018 Sep 18;8(1):1-6. doi: 10.1007/s13691-018-0344-z. eCollection 2019 Jan. Erratum in: Int Cancer Conf J. 2019 Sep 3;8(4):195-196.

5.

Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report.

Takuwa H, Tsuji W, Shintaku M, Yotsumoto F.

BMC Cancer. 2018 Dec 22;18(1):1282. doi: 10.1186/s12885-018-5216-6.

6.

Patients who achieved long-term clinical complete response and subsequently terminated multidisciplinary and anti-HER2 therapy for metastatic breast cancer: A case series.

Takuwa H, Tsuji W, Yotsumoto F.

Int J Surg Case Rep. 2018;52:125-131. doi: 10.1016/j.ijscr.2018.10.008. Epub 2018 Oct 12.

7.
8.
9.

Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis.

Cheng LE, Amoura Z, Cheah B, Hiepe F, Sullivan BA, Zhou L, Arnold GE, Tsuji WH, Merrill JT, Chung JB.

Arthritis Rheumatol. 2018 Jul;70(7):1071-1076. doi: 10.1002/art.40479. Epub 2018 May 25.

10.

Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaboration.

Cope AP, Barnes MR, Belson A, Binks M, Brockbank S, Bonachela-Capdevila F, Carini C, Fisher BA, Goodyear CS, Emery P, Ehrenstein MR, Gozzard N, Harris R, Hollis S, Keidel S, Levesque M, Lindholm C, McDermott MF, McInnes IB, Mela CM, Parker G, Read S, Pedersen AW, Ponchel F, Porter D, Rao R, Rowe A, Schulze-Knappe P, Sleeman MA, Symmons D, Taylor PC, Tom B, Tsuji W, Verbeeck D, Isaacs JD; RA-MAP Consortium.

Nat Rev Rheumatol. 2018 Jan 24;14(2):119. doi: 10.1038/nrrheum.2018.6.

PMID:
29362468
11.

An Animal Model of Local Breast Cancer Recurrence in the Setting of Autologous Fat Grafting for Breast Reconstruction.

Tsuji W, Valentin JE, Marra KG, Donnenberg AD, Donnenberg VS, Rubin JP.

Stem Cells Transl Med. 2018 Jan;7(1):125-134. doi: 10.1002/sctm.17-0062.

12.

The RA-MAP Consortium: a working model for academia-industry collaboration.

Cope AP, Barnes MR, Belson A, Binks M, Brockbank S, Bonachela-Capdevila F, Carini C, Fisher BA, Goodyear CS, Emery P, Ehrenstein MR, Gozzard N, Harris R, Hollis S, Keidel S, Levesque M, Lindholm C, McDermott MF, McInnes IB, Mela CM, Parker G, Read S, Pedersen AW, Ponchel F, Porter D, Rao R, Rowe A, Schulz-Knappe P, Sleeman MA, Symmons D, Taylor PC, Tom B, Tsuji W, Verbeeck D, Isaacs JD; RA-MAP Consortium.

Nat Rev Rheumatol. 2018 Jan;14(1):53-60. doi: 10.1038/nrrheum.2017.200. Epub 2017 Dec 7. Review. Erratum in: Nat Rev Rheumatol. 2018 Jan 24;14 (2):119.

13.

Palliative surgery for giant mucinous carcinoma of the breast in an elderly patient: A rare case report.

Takuwa H, Tsuji W, Yotsumoto F.

Mol Clin Oncol. 2017 Oct;7(4):609-614. doi: 10.3892/mco.2017.1386. Epub 2017 Aug 21.

14.

Pros and cons of immediate Vicryl mesh insertion after lumpectomy.

Tsuji W, Yotsumoto F.

Asian J Surg. 2018 Nov;41(6):537-542. doi: 10.1016/j.asjsur.2017.08.001. Epub 2017 Aug 18.

15.

Chondrolipoma of the breast as a rare variant of myofibroblastoma: an immunohistochemical study of two cases.

Shintaku M, Yamamoto Y, Kono F, Kitai T, Tsuji W, Yotsumoto F, Kushima R.

Virchows Arch. 2017 Oct;471(4):531-535. doi: 10.1007/s00428-017-2179-y. Epub 2017 Jun 26.

PMID:
28653201
16.

Single Implantable FK506 Disk Prevents Rejection in Vascularized Composite Allotransplantation.

Unadkat JV, Schnider JT, Feturi FG, Tsuji W, Bliley JM, Venkataramanan R, Solari MG, Marra KG, Gorantla VS, Spiess AM.

Plast Reconstr Surg. 2017 Feb;139(2):403e-414e. doi: 10.1097/PRS.0000000000002951.

PMID:
28121868
17.

The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.

Plock JA, Schnider JT, Schweizer R, Zhang W, Tsuji W, Waldner M, Solari MG, Marra KG, Rubin JP, Gorantla VS.

Transplantation. 2017 Jan;101(1):e1-e11. doi: 10.1097/TP.0000000000001498.

18.

Localized primary amyloidosis of the breast: a case report and review of the literature.

Tsuji W, Takeuchi E, Oka S, Yamashita T, Yotsumoto F.

BMC Surg. 2016 Sep 13;16(1):62. doi: 10.1186/s12893-016-0178-6. Review.

19.

Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus.

Sullivan BA, Tsuji W, Kivitz A, Peng J, Arnold GE, Boedigheimer MJ, Chiu K, Green CL, Kaliyaperumal A, Wang C, Ferbas J, Chung JB.

Lupus Sci Med. 2016 Apr 8;3(1):e000146. doi: 10.1136/lupus-2016-000146. eCollection 2016.

20.

Modeling the pharmacokinetic-pharmacodynamic relationship of the monoclonal anti-macaque-IL-15 antibody Hu714MuXHu in cynomolgus monkeys.

Pan WJ, Li H, Xiao JJ, Horner MJ, Lebrec HN, Butz EA, Kaliyaperumal A, Cheah TC, Ortiz RC, Prokop SP, Buntich SA, Boren BM, Wolford ST, Tsuji WH, Wienkers LC, Köck K.

Pharmacol Res Perspect. 2016 Jan 11;3(6):e00199. doi: 10.1002/prp2.199. eCollection 2015 Dec.

21.

Gene expression changes triggered by end-of-day far-red light treatment on early developmental stages of Eustoma grandiflorum (Raf.) Shinn.

Takemura Y, Kuroki K, Katou M, Kishimoto M, Tsuji W, Nishihara E, Tamura F.

Sci Rep. 2015 Dec 8;5:17864. doi: 10.1038/srep17864.

22.

Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects.

Gow JM, Tsuji WH, Williams GJ, Mytych D, Sciberras D, Searle SL, Mant T, Gibbs JP.

Arthritis Res Ther. 2015 Oct 8;17:282. doi: 10.1186/s13075-015-0797-9.

23.

Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials.

Stohl W, Merrill JT, Looney RJ, Buyon J, Wallace DJ, Weisman MH, Ginzler EM, Cooke B, Holloway D, Kaliyaperumal A, Kuchimanchi KR, Cheah TC, Rasmussen E, Ferbas J, Belouski SS, Tsuji W, Zack DJ.

Arthritis Res Ther. 2015 Aug 20;17:215. doi: 10.1186/s13075-015-0741-z.

24.

Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.

Plock JA, Schnider JT, Zhang W, Schweizer R, Tsuji W, Kostereva N, Fanzio PM, Ravuri S, Solari MG, Cheng HY, Rubin PJ, Marra KG, Gorantla VS.

Transplantation. 2015 Sep;99(9):1765-73. doi: 10.1097/TP.0000000000000731.

25.

The role of adipose-derived stem cells in breast cancer progression and metastasis.

Schweizer R, Tsuji W, Gorantla VS, Marra KG, Rubin JP, Plock JA.

Stem Cells Int. 2015;2015:120949. doi: 10.1155/2015/120949. Epub 2015 Apr 27. Review.

26.

Effects of immunosuppressive drugs on viability and susceptibility of adipose- and bone marrow-derived mesenchymal stem cells.

Tsuji W, Schnider JT, McLaughlin MM, Schweizer R, Zhang W, Solari MG, Rubin JP, Marra KG, Plock JA, Gorantla VS.

Front Immunol. 2015 Apr 16;6:131. doi: 10.3389/fimmu.2015.00131. eCollection 2015.

27.

Preclinical development of AMG 139, a human antibody specifically targeting IL-23.

Köck K, Pan WJ, Gow JM, Horner MJ, Gibbs JP, Colbert A, Goletz TJ, Newhall KJ, Rees WA, Sun Y, Zhang Y, O'Neill JC, Umble-Romero AN, Prokop SP, Krill CD, Som L, Buntich SA, Trimble MW, Tsuji WH, Towne JE.

Br J Pharmacol. 2015 Jan;172(1):159-72. doi: 10.1111/bph.12904. Epub 2014 Dec 15.

28.

Adipose-derived stem cells: Implications in tissue regeneration.

Tsuji W, Rubin JP, Marra KG.

World J Stem Cells. 2014 Jul 26;6(3):312-21. doi: 10.4252/wjsc.v6.i3.312. Review.

29.

Abstract 128: developing tumor-suppressing autologous fat grafts for breast cancer survivors.

Valentin J, Tsuji W, Chung C, McLaughlin M, Marra K, Donnenberg V, Donnenberg A, Rubin JP.

Plast Reconstr Surg. 2014 Mar;133(3 Suppl):144-5. doi: 10.1097/01.prs.0000444955.51667.c5. No abstract available.

PMID:
25942239
30.

Homeostasis of human NK cells is not IL-15 dependent.

Lebrec H, Horner MJ, Gorski KS, Tsuji W, Xia D, Pan WJ, Means G, Pietz G, Li N, Retter M, Shaffer K, Patel N, Narayanan PK, Butz EA.

J Immunol. 2013 Dec 1;191(11):5551-8. doi: 10.4049/jimmunol.1301000. Epub 2013 Nov 1.

31.

Orally administered S-1 suppresses circulating endothelial cell counts in metastatic breast cancer patients.

Tsuji W, Ishiguro H, Tanaka S, Takeuchi M, Ueno T, Toi M.

Int J Clin Oncol. 2014;19(3):452-9. doi: 10.1007/s10147-013-0570-5. Epub 2013 Jun 6.

32.

Simple and longstanding adipose tissue engineering in rabbits.

Tsuji W, Inamoto T, Ito R, Morimoto N, Tabata Y, Toi M.

J Artif Organs. 2013 Mar;16(1):110-4. doi: 10.1007/s10047-012-0670-4. Epub 2012 Nov 1.

33.

Adipogenesis using human adipose tissue-derived stromal cells combined with a collagen/gelatin sponge sustaining release of basic fibroblast growth factor.

Ito R, Morimoto N, Liem PH, Nakamura Y, Kawai K, Taira T, Tsuji W, Toi M, Suzuki S.

J Tissue Eng Regen Med. 2014 Dec;8(12):1000-8. doi: 10.1002/term.1611. Epub 2012 Sep 21.

PMID:
22997068
34.

Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institution.

Tsuji W, Teramukai S, Ueno M, Toi M, Inamoto T.

Breast Cancer. 2014 Jan;21(1):86-95. doi: 10.1007/s12282-012-0358-x. Epub 2012 Apr 5.

35.

Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience.

Peterfy CG, Countryman P, Gabriele A, Shaw T, Anisfeld A, Tsuji W, Olech E, Gaylis NB, Conaghan PG, Strand V, Dicarlo J.

J Rheumatol. 2011 Sep;38(9):2023-30. doi: 10.3899/jrheum.110418.

PMID:
21885511
36.

A review of current animal models of osteoarthritis pain.

D'Souza WN, Ng GY, Youngblood BD, Tsuji W, Lehto SG.

Curr Pharm Biotechnol. 2011 Oct;12(10):1596-612. Review.

PMID:
21466452
37.

OARSI-FDA initiative: defining the disease state of osteoarthritis.

Lane NE, Brandt K, Hawker G, Peeva E, Schreyer E, Tsuji W, Hochberg MC.

Osteoarthritis Cartilage. 2011 May;19(5):478-82. doi: 10.1016/j.joca.2010.09.013. Epub 2011 Mar 23.

38.

[Basic fibroblast growth factor (FGF-2)].

Tsuji W, Yamashiro H, Toi M.

Nihon Rinsho. 2010 Jul;68 Suppl 7:118-20. Japanese. No abstract available.

PMID:
20960759
39.

Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis.

Mease PJ, Woolley JM, Singh A, Tsuji W, Dunn M, Chiou CF.

J Rheumatol. 2010 Jun;37(6):1221-7. doi: 10.3899/jrheum.091093. Epub 2010 Apr 15.

40.

Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients.

Deodhar A, Dore RK, Mandel D, Schechtman J, Shergy W, Trapp R, Ory PA, Peterfy CG, Fuerst T, Wang H, Zhou L, Tsuji W, Newmark R.

Arthritis Care Res (Hoboken). 2010 Apr;62(4):569-74. doi: 10.1002/acr.20004.

41.

Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis.

Sharp JT, Tsuji W, Ory P, Harper-Barek C, Wang H, Newmark R.

Arthritis Care Res (Hoboken). 2010 Apr;62(4):537-44. doi: 10.1002/acr.20172.

42.

The involvement of lipid peroxide-derived aldehydes in aluminum toxicity of tobacco roots.

Yin L, Mano J, Wang S, Tsuji W, Tanaka K.

Plant Physiol. 2010 Mar;152(3):1406-17. doi: 10.1104/pp.109.151449. Epub 2009 Dec 18.

43.

Overexpression of dehydroascorbate reductase, but not monodehydroascorbate reductase, confers tolerance to aluminum stress in transgenic tobacco.

Yin L, Wang S, Eltayeb AE, Uddin MI, Yamamoto Y, Tsuji W, Takeuchi Y, Tanaka K.

Planta. 2010 Feb;231(3):609-21. doi: 10.1007/s00425-009-1075-3. Epub 2009 Dec 4.

PMID:
19960204
44.

Increased UV-B radiation affects the viability, reactive oxygen species accumulation and antioxidant enzyme activities in maize (Zea mays L.) pollen.

Wang S, Xie B, Yin L, Duan L, Li Z, Eneji AE, Tsuji W, Tsunekawa A.

Photochem Photobiol. 2010 Jan-Feb;86(1):110-6. doi: 10.1111/j.1751-1097.2009.00635.x. Epub 2009 Nov 10.

PMID:
19906093
45.

In situ adipogenesis in fat tissue augmented by collagen scaffold with gelatin microspheres containing basic fibroblast growth factor.

Kimura Y, Tsuji W, Yamashiro H, Toi M, Inamoto T, Tabata Y.

J Tissue Eng Regen Med. 2010 Jan;4(1):55-61. doi: 10.1002/term.218.

PMID:
19830791
46.

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates.

Dore RK, Cohen SB, Lane NE, Palmer W, Shergy W, Zhou L, Wang H, Tsuji W, Newmark R; Denosumab RA Study Group.

Ann Rheum Dis. 2010 May;69(5):872-5. doi: 10.1136/ard.2009.112920. Epub 2009 Sep 3.

47.

Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.

Toi M, Yamashiro H, Tsuji W.

Breast Cancer. 2009;16(3):207-18. doi: 10.1007/s12282-009-0096-x. Epub 2009 Mar 4. Review.

48.

Adipogenesis induced by human adipose tissue-derived stem cells.

Tsuji W, Inamoto T, Yamashiro H, Ueno T, Kato H, Kimura Y, Tabata Y, Toi M.

Tissue Eng Part A. 2009 Jan;15(1):83-93. doi: 10.1089/ten.tea.2007.0297.

49.

Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.

van der Heijde D, Landewé R, Einstein S, Ory P, Vosse D, Ni L, Lin SL, Tsuji W, Davis JC Jr.

Arthritis Rheum. 2008 May;58(5):1324-31. doi: 10.1002/art.23471.

50.

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.

Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R; Denosumab Rheumatoid Arthritis Study Group.

Arthritis Rheum. 2008 May;58(5):1299-309. doi: 10.1002/art.23417.

Supplemental Content

Support Center